ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas

Wei, Q. T.; Liu, B. Y.; Ji, H. Y.; Lan, Y. F.; Tang, W. H.; Zhou, J.; Zhong, X. Y.; Lian, C. L.; Huang, Q. Z.; Wang, C. Y.; Xu, Y. M.; Guo, H. B.*南方医科大学; 汕头大学; 1
Molecular Therapy-Oncolytics2021-9-24DOI: 10.1016/j.omto.2021.08.004
18被引15阅读
引用收藏
分享

摘要

Temozolomide (TMZ) resistance is an important cause of clinical treatment failure and poor prognosis in gliomas. Increasing evidence indicates that cancer-derived exosomes contribute to chemoresistance; however, the specific contribution of glioma-derived exosomes remains unclear. The aim of this study was to explore the role and underlying mechanisms of exosomal macrophage migration inhibitory factor (MIF) on TMZ resistance in gliomas. We first demonstrated that MIF was upregulated in the exosomes of TMZ-resistant cells, engendering the transfer of TMZ resistance to sensitive cells. Our results indicated that exosomal MIF conferred TMZ resistance to sensitive cells through the enhancement of cell proliferation and the repression of cell apoptosis upon TMZ exposure. MIF knockdown enhanced TMZ sensitivity in resistant glioma cells by upregulating Metalloproteinase Inhibitor 3 (TIMP3) and subsequently suppressing the PI3K/AKT signaling pathway. Additionally, exosomal MIF promoted tumor growth and TMZ resistance of glioma cells in vivo, while IOS-1 (MIF inhibitor) promotes glioma TMZ sensitive in vivo. Taken together, our study demonstrated that exosome-mediated transfer of MIF enhanced TMZ resistance in glioma through downregulating TIMP3 and further activating the PI3K/AKT signaling pathway, highlighting a prognostic biomarker and promising therapeutic target for TMZ treatment in gliomas.

学科与关键词

关键词
BREAST-CANCER CELLSLONG NONCODING RNAMESSENGER-RNAPROMOTESPTENPROLIFERATIONMETASTASISEXPRESSIONAUTOPHAGYBIOLOGY
相关
加载中…
  • Interaction of SENP6 with PINK1 Promotes Temozolomide Resistance in Neuroglioma Cells via Inducing the Mitophagy
    Wang, Y. W.; Jia, K. G.; Xing, H. J.; Pan, Y.; Zeng, C. S.; Chen, L.; Su, Q. J.; Shen, W. T.; Chen, J.; Chen, C.*; Cao, Q.*; Wang, Y. Y.MOLECULAR BIOLOGY, 2023, 57(6): 1228-1238.
  • Serum-derived extracellular vesicles facilitate temozolomide resistance in glioblastoma through a HOTAIR-dependent mechanism
    Wang, Xiaosong; Yu, Xiaojun; Xu, Haoran; Wei, Kang; Wang, Shanxi; Wang, Yingguang; Han, Junfei*Cell Death & Disease, 2022, 13(4): 344.被引 13
  • Prrx1 promotes resistance to temozolomide by upregulating ABCC1 and inducing vasculogenic mimicry in glioma
    Chen, Zetao; Zhang, Yujie; Chen, Yihong; Lin, Wanmei; Zhang, Yuxuan; Cai, Guixing; Sun, Xinlin; Zheng, Kehong; He, Jie; Ai, Tianjing; Wang, Jihui*; Zhao, Liang*; Ke, Yiquan*American Journal of Cancer Research, 2022, 12(8): 3892-+.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Therapy-Oncolytics
发表日期
2021-09-24
卷期
第 22 卷
页码
114-128
DOI
10.1016/j.omto.2021.08.004
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2017A030308001]; NationalNatural Science Foundation of China [81874079, 82073193]; Guangdong Medical Science and Technology Research Fund Project, China [A2020535]; Guangdong Provincial Clinical Medical Centre for Neurosurgery [2013B020400005]

作者

  • W

    Wei, Q. T. (第一作者)

    1 · shantou univ · southern med univ

  • L

    Liu, B. Y.

    southern med univ

查看全部 12 位作者收起作者
  • J

    Ji, H. Y.

    1 · shantou univ · southern med univ

  • L

    Lan, Y. F.

    southern med univ

  • T

    Tang, W. H.

    southern med univ

  • Z

    Zhou, J.

    southern med univ

  • Z

    Zhong, X. Y.

    southern med univ

  • L

    Lian, C. L.

    southern med univ

  • H

    Huang, Q. Z.

    southern med univ

  • W

    Wang, C. Y.

    southern med univ

  • X

    Xu, Y. M.

    1 · shantou univ

  • G

    Guo, H. B. (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417